CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Psychometric Validation Moves Closer to Market Access Discussions in Canada

By

Life Sciences Review | Thursday, June 11, 2026

A questionnaire can perform well in one country and still create problems when introduced elsewhere. That reality is drawing greater attention to psychometric and linguistic validations performed in Canada. At the moment, many stakeholders are looking for instruments that will function equally efficiently when applied to representatives of various language groups.


The problem does not concern only translation issues since a direct language conversion might result in preserved wording and changed meanings. Questions appearing straightforward in one population may have completely different implications when evaluated by others. Therefore, organizations conducting patient-reported outcomes surveys, educational assessments and other types of testing need to pay particular attention to the matter to make sure that the collected information is interpretable.


When it comes to validation in Canada, there is no simple approach involving two main languages. In practice, the task includes examination of cultural background, reading level and response options used in the questionnaire. The objective is to evaluate an instrument rather than translate it.


Today, organizations working with various health and social organizations are paying attention to the matter since measurement validity has become crucial for research quality. Consequently, the problem becomes obvious when sponsors are expected to interpret their data correctly despite possible discrepancies between language versions of the instrument.


At the same time, the trend influences the process of instrument selection and development. Today, many organizations do not leave testing until the end of the project but conduct thorough psychometric reviews before choosing an assessment. It seems reasonable considering the possibility of identifying potential issues beforehand rather than solving them later.


Besides, many stakeholders currently use the outputs from various surveys for further decision-making regarding programs and policies. Under such conditions, the issue gains new importance. Organizations using data to guide their operations have higher needs for validated instruments because findings might impact the provision of services or funding of programs.


It means that the discussion of validation services has changed significantly in recent years in terms of requirements from sponsors. Buyers are not satisfied with linguistic analysis performed without testing. On the contrary, they expect a provider to follow all standard requirements for evidence generation and evaluation of an instrument.


Nevertheless, the extent of activities performed to validate a questionnaire depends on the use of an instrument and a target population. Not all organizations need the most rigorous process to develop their tool. Sometimes, simpler approaches work equally well. Thus, organizations should choose an appropriate solution based on their needs.


Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/state-of-industry/psychometric-validation-moves-closer-to-market-access-discussions-in-canada-nwid-3415.html